Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
H&T Group
1H’24 results: Four-one at half time, but the one wins
20th Aug 2024
Surface Transforms
Pre-close trading, AGM and prospects
13th Aug 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
101: Why fintech is still important in UK venture capital | Marcus Love and Adrian Love of Love Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Primary Health Properties
Investment Companies
Gilt edged rent collector – accelerating dividends
By
Mike Foster
23 Nov 2017
Redx Pharma
Life Sciences
Streamlined and clean
By
Dr Martin Hall
13 Nov 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Chamberlin Plc
Industrial
One-off cost inefficiencies lead to lower forecasts
By
Paul Singer
18 Oct 2017
Alliance Pharma Plc
Life Sciences
Kelo-cote building international sales
By
Dr Martin Hall
17 Oct 2017
Avacta Group plc
Life Sciences
R&D accelerated to advance assets
By
Dr Martin Hall
16 Oct 2017
Tissue Regenix
Life Sciences
Dual revenue stream growth
11 Oct 2017
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Martin Hall
10 Oct 2017
City of London Investment Group
Financials
Q1 showing steady growth
By
Dr Brian Moretta
10 Oct 2017
ValiRx
Life Sciences
Progressing all the pipeline
06 Oct 2017
Scancell Holdings
Life Sciences
Preparing for next clinical studies
By
Dr Martin Hall
03 Oct 2017
Advanced Oncotherapy
Life Sciences
Technology advances & stronger balance sheet
By
Dr Martin Hall
02 Oct 2017
Prev
1
...
22
23
24
25
26
...
29
Next